RMD Q3 2022 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$865M+12.5% YoY

Gross Profit

$491M56.8% margin

Operating Income

$234M27.1% margin

Net Income

$179M20.7% margin

EPS (Diluted)

$1.22

QoQ Revenue Growth

-3.4%

Cash Flow

Operating Cash Flow

$117M

Free Cash Flow

$65M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.9B

Total Liabilities

$1.6B

Stockholders' Equity

$3.3B

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$865M	$769M	+12.5%
Gross Profit	$491M	$447M	+9.8%
Operating Income	$234M	$223M	+4.9%
Net Income	$179M	-$78M	+328.1%

Revenue Segments

Sleep And Respiratory

$763M88%

Software As Service

$101M12%

Geographic Segments

Us Canada And Latin America

$577M67%

Combined Europe Asia And Other Markets

$288M33%